Autoimmune hepatitis and primary biliary cholangitis overlap syndrome after COVID-19
Marlone Cunha-Silva; Eloy Vianey Carvalho de França; Raquel Dias Greca; Daniel Ferraz de Campos Mazo; Larissa Bastos Eloy da Costa; Priscilla Brito Sena de Moraes; Clauber Teles Veiga; Guilherme Rossi Assis-Mendonça; Ilka de Fátima Santana Ferreira Boin; Raquel Silveira Bello Stucchi; Tiago Sevá-Pereira
Abstract
Keywords
References
1 Dotan A, David P, Arnheim D, Shoenfeld Y. The autonomic aspects of the post-COVID19 syndrome. Autoimmun Rev. 2022;21(5):103071.
2 Liu Y, Sawalha AH, Lu Q. COVID-19 and autoimmune diseases. Curr Opin Rheumatol. 2021;33(2):155-62.
3 Kabaçam G, Wahlin S, Efe C. Autoimmune hepatitis triggered by COVID-19: a report of two cases. Liver Int. 2021;41(10):2527-8.
4 Bartoli A, Cursaro C, Andreone P. Severe acute respiratory syndrome coronavirus-2-associated cholangiopathies. Curr Opin Gastroenterol. 2022;38(2):89-97.
5 Floreani A, De Martin S. COVID-19 and autoimmune liver diseases. J Clin Med. 2022;11(10):2681.
6 Erard D, Villeret F, Lavrut PM, Dumortier J. Autoimmune hepatitis developing after COVID 19 vaccine: presumed guilty? Clin Res Hepatol Gastroenterol. 2022;46(3):101841.
7 Chazouillères O, Wendum D, Serfaty L, Montembault S, Rosmorduc O, Poupon R. Primary biliary cirrhosis-autoimmune hepatitis overlap syndrome: clinical features and response to therapy. Hepatology. 1998;28(2):296-301.
8 Vitrone M, Mele F, Durante-Mangoni E, Zampino R. Drugs and liver injury: a not to be overlooked binomial in COVID-19. J Chemother. 2022;34(4):207-20.
9 National Institute of Diabetes and Digestive and Kidney Diseases. LiverTox: Clinical and Research Information on Drug-Induced Liver Injury. Azithromycin [Internet]. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2021. Available from: April 25, 2022. Available from:
10 Martinez MA, Vuppalanchi R, Fontana RJ, et al. Clinical and histologic features of azithromycin-induced liver injury. Clin Gastroenterol Hepatol. 2015;13(2):369-76.e3.
11 Ellison CA, Blackwell SB. Acute hepatocellular injury associated with Azithromycin. J Pharm Pract. 2021;34(3):493-6.
12 Chalasani N, Bonkovsky HL, Fontana R, et al. Features and outcomes of 899 patients with drug-induced liver injury: the DILIN prospective study. Gastroenterology. 2015;148(7):1340-1352.e7.
13 Björnsson ES, Andrade RJ. Long-term sequelae of drug-induced liver injury. J Hepatol. 2022;76(2):435-45.
14 Freedman BL, Danford CJ, Patwardhan V, Bonder A. Treatment of overlap syndromes in autoimmune liver disease: a systematic review and meta-analysis. J Clin Med. 2020;9(5):1449.
15 Couto CA, Terrabuio DRB, Cançado ELR, et al. Update of the brazilian society of hepatology recommendations for diagnosis and management of autoimmune diseases of the liver. Arq Gastroenterol. 2019;56(2):232-41.
16 Jiang Y, Xu BH, Rodgers B, Pyrsopoulos N. Characteristics and inpatient outcomes of primary biliary cholangitis and autoimmune hepatitis overlap syndrome. J Clin Transl Hepatol. 2021;9(3):392-8.
17 Tan XY, Miao Q, Chen XY. Clinicopathological analysis of anti-mitochondrial antibody negative primary biliary cholangitis-autoimmune hepatitis overlap syndrome. Zhonghua Gan Zang Bing Za Zhi. 2019;27(5):376-80.
18 Nardo AD, Schneeweiss-Gleixner M, Bakail M, Dixon ED, Lax SF, Trauner M. Pathophysiological mechanisms of liver injury in COVID-19. Liver Int. 2021;41(1):20-32.
19 Bartoli A, Gitto S, Sighinolfi P, Cursaro C, Andreone P. Primary biliary cholangitis associated with SARS-CoV-2 infection. J Hepatol. 2021;74(5):1245-6.
20 Cesar Machado MC, Kalil R Fo, El Bacha IAH, et al. Post-COVID-19 secondary sclerosing cholangitis: a rare but severe condition with no treatment besides liver transplantation. Am J Case Rep. 2022;23:e936250.
21 Roth NC, Kim A, Vitkovski T, et al. Post-COVID-19 cholangiopathy: a novel entity. Am J Gastroenterol. 2021;116(5):1077-82.
22 Andrés L, Badia E, Fernández C, et al. Autoimmune hepatitis. Another consequence of COVID-19? Gastroenterol Hepatol. 2023;46(2):135-6.
23 Izagirre A, Arzallus T, Garmendia M, Torrente S, Castiella A, Zapata EM. Autoimmune hepatitis following COVID-19 vaccination. J Autoimmun. 2022;132:102874.
24 Singh B, Kaur P, Maroules M. Autoimmune hepatitis-primary biliary cholangitis overlap syndrome triggered by COVID-19. Eur J Case Rep Intern Med. 2021;8(3):002264.
25 To U, Silveira M. Overlap syndrome of autoimmune hepatitis and primary biliary cholangitis. Clin Liver Dis. 2018;22(3):603-11.
26 Silveira MG, Talwalkar JA, Angulo P, Lindor KD. Overlap of autoimmune hepatitis and primary biliary cirrhosis: long-term outcomes. Am J Gastroenterol. 2007;102(6):1244-50.
27 Liu JM, Chi J. Is COVID-19-associated cytokine storm distinct from non-COVID-19 secondary hemophagocytic lymphohistiocytosis? Exp Biol Med (Maywood). 2022;247(4):330-7.
Submitted date:
10/23/2022
Accepted date:
02/10/2022
Publication date:
03/10/2023
Facebook
Google+
Twitter
LinkedIn
Mendeley
StumbleUpon
CiteULike
Reddit
Email